HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and genetic studies of 3 large, consanguineous, Algerian families with Mal de Meleda.

AbstractBACKGROUND:
Mal de Meleda (MIM 248300), also referred to as keratosis palmoplantaris transgrediens of Siemens, is a rare autosomal recessive skin disorder with a prevalence in the general population of 1 in 100,000. The main clinical characteristics are transgressive palmoplantar keratoderma, hyperhidrosis, and perioral erythema, but there are also associated features such as brachydactyly, nail abnormalities, and lichenoid plaques.
OBSERVATIONS:
We studied the clinical and genetic characteristics of 3 large, consanguineous, Algerian families, including 14 affected individuals. Homozygosity mapping of the third family confirmed localization of the responsible gene to 8qter in all 3 families.
CONCLUSIONS:
Although some differences in phenotypic expression among subjects were noted, genetic analysis of the 3 families who shared a common ethnic background indicated that a single gene is responsible for mal de Meleda in this population.
AuthorsB Bouadjar, S Benmazouzia, J F Prud'homme, S Cure, J Fischer
JournalArchives of dermatology (Arch Dermatol) Vol. 136 Issue 10 Pg. 1247-52 (Oct 2000) ISSN: 0003-987X [Print] United States
PMID11030771 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Keratolytic Agents
  • Acitretin
Topics
  • Acitretin (therapeutic use)
  • Adolescent
  • Adult
  • Algeria
  • Child
  • Child, Preschool
  • Consanguinity
  • Female
  • Genetic Linkage
  • Haplotypes
  • Humans
  • Infant
  • Keratoderma, Palmoplantar (drug therapy, genetics, pathology)
  • Keratolytic Agents (therapeutic use)
  • Male
  • Pedigree

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: